PRC2-Inactivating Mutations in Cancer Enhance Cytotoxic Response to DNMT1-Targeted Therapy via Enhanced Viral Mimicry is a research paper published in Cancer Discovery (2022). On theSindex it has a DataRank of 0. It has been cited 33 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NIH NCI
Grant: R01 CA228216
NIH NCI
Grant: DP2 CA174499
Department of Defense
Grant: W81XWH-15-1-0124
Department of Defense
Grant: W81XWH-22-1-0326
NIH NCI
Grant: P50 CA217694
NIH NCI
Grant: 5R01CA208100-04
NIH NCI
Grant: 5U54CA224079-03
NIH NCI
Grant: 5P50CA092629-20
Geoffrey Beene Cancer Research Fund Department of Defense Horizon Award
Grant: CA181474
Translational Oncology Research in Oncology Training Program T32 NIH NCI
Grant: 5T32CA160001-09
NIH
Grant: P30 CA 008748
NCI Cancer Center Support Grant
Grant: P30 CA08748
NCI NIH HHS
Grant: P50 CA092629
NCI NIH HHS
Grant: R01 CA208100
NCI NIH HHS
Grant: R01 CA280657
NCI NIH HHS
Grant: T32 CA160001
NCI NIH HHS
Grant: U54 CA224079
NCI NIH HHS
Grant: K08 CA151660
FDA HHS
Grant: R01 FD007544
NCI NIH HHS
Grant: U01 CA252048
MeSH Terms